About SR2B
SR2B is a Healthcare company based in Angers (France) founded in 1984, and was acquired by Biosynex in June 2017. Developer of reagents for microbiology. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
SR2B was established in 1984 in Angers, France, within the biotechnology sector. Reagents for microbiology applications are produced, emphasizing parasitic and fungal antigens alongside monoclonal antibodies. Lyophilization processes for bioproducts are utilized, and microparticles are coupled with macromolecules to support diagnostic and research needs. Operations remain centered on these specialized development activities in the European market.
Investors in SR2B
SR2B has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biosynex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Professional rapid diagnostic tests for diseases are manufactured by Biosynex. | 2005 | biosynex.com | Strasbourg, France |
Investor details for SR2B
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SR2B
2 dated milestones of SR2B across 33 years, from founding to its latest funding, stage changes and deals.
- Founded SR2B is founded.
- Exit Acquired by Biosynex.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SR2B
SR2B was founded in 1984.
SR2B is headquartered in Angers, France. It is registered at Angers, Pays De La Loire, France.
SR2B was established in 1984 in Angers, France, within the biotechnology sector. Reagents for microbiology applications are produced, emphasizing parasitic and fungal antigens alongside monoclonal antibodies. Lyophilization processes for bioproducts are utilized, and microparticles are coupled with macromolecules to support diagnostic and research needs. Operations remain centered on these specialized development activities in the European market.
SR2B has 1 investor. Key investors include Biosynex.
Yes. SR2B was acquired by Biosynex in June 2017.